Marcie Black | CEO
ASG

Marcie Black, CEO, ASG

Marcie Black is CEO and co-founder of Advanced Silicon Group.  Dr. Black brings to the company expertise in building strong teams, managing development projects, patents, IP strategy, encouraging a healthy company culture, cost modeling, and running a startup.  In addition, Dr. Black has a strong technical background in the areas of electronic materials, optics, semiconductors, solar cells/photovoltaics, batteries, renewable energy, nanotechnology, device design, and opto-electronics. 

Prior to founding ASG, Marcie was the President and co-founder of Bandgap Engineering, which focused on lowering the cost of solar electricity through black silicon or silicon nanowire solar cells.  Before joining Bandgap, Marcie was a technical staff member at Los Alamos National Laboratory and worked on a variety of nanotechnology and optical systems.  She began at Los Alamos National Labs as a prestigious Director’s Funded Post Doc, developing organic and nano solar cells. Marcie has a Ph.D. from MIT in Electrical Engineering, under the supervision of Institute Professor, Mildred Dresselhaus.  Prior to her Ph.D. work, Marcie was a device engineer at Motorola where she was on a small team responsible for combining non-volatile memory and logic onto the same chip.  She improved the manufacturing yields by working with the process engineer to improve silicide formation.  In 2009, she was awarded an R&D 100 award for her contributions to work at LANL.  Marcie also was honored as one of the ten “Women-to-Watch in 2010” by Mass High Tech.  Marcie has published over 30+ papers, given two TedxTalks, and has a long list of patents issued.

Appearances:



Festival of Biologics Day 2 @ 11:40

From Hours to Minutes: Rapid Protein Measurement for Bioprocess Development and Manufacturing

Biologics development and manufacturing require the measurement of proteins throughout the process—from monitoring critical process parameters and product quality attributes to detecting impurities and contaminants. However, many protein measurements still rely on laboratory-based assays that take hours or longer to return results, require skilled technicians, and involve multiple reagent addition and washing steps. As a result, important protein measurements are often performed only at selected points in development or as end-point quality tests rather than being used to guide processes in near real time.

Rapid, protein-specific measurements could provide valuable information during both process development and manufacturing. During development, faster measurements could allow scientists to evaluate process changes more quickly and better understand how these changes affect the product. During manufacturing, at-line protein measurements could identify process deviations earlier, potentially reducing lost batches, manufacturing delays, and costs while enabling greater process control and automation. Host cell proteins (HCPs) provide an important example. HCPs can co-purify with a therapeutic protein, and some may affect product stability, efficacy, or patient safety.

Advanced Silicon Group (ASG) is developing NanoSwift™, a silicon-based, label-free electrical biosensor platform designed for rapid, quantitative protein measurements. The technology is intended to measure specific proteins in less than 15 minutes with minimal hands-on time and low sample volume. Because NanoSwift generates an electrical signal and can be multiplexed to measure multiple proteins, it has the potential to support automated, at-line measurements during biologics development and manufacturing.

This presentation will discuss the opportunities created by moving protein measurements closer to the bioprocess, including applications in process development, process monitoring, product characterization, and impurity detection. High-risk HCP measurement will be presented as one example of how rapid, protein-specific measurements could provide information that is difficult to obtain with current methods. Ultimately, faster access to protein data could help biopharmaceutical manufacturers develop processes more efficiently, identify problems earlier, improve process control, and manufacture biologics more consistently.

last published: 18/Nov/26 17:29 GMT

back to speakers

Get involved at Festival of Biologics USA 2027

 

 

TO SPONSOR


Nicholas Matthews

Nicholas.Matthews@terrapinn.com

 

 

TO SPEAK


Jack Beard
Jack.Beard@terrapinn.com

 

MARKETING & PRESS


Ollie McDaid

Ollie.Mcdaid@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.